3-Bromo-6,7-dihydro-5H-cyclopenta[B]pyridin-7-ol - CAS 1379342-51-4
Catalog: |
BB061900 |
Product Name: |
3-Bromo-6,7-dihydro-5H-cyclopenta[B]pyridin-7-ol |
CAS: |
1379342-51-4 |
Synonyms: |
3-BROMO-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDIN-7-OL; 3-bromo-5H,6H,7H-cyclopenta[b]pyridin-7-ol |
IUPAC Name: | 3-bromo-6,7-dihydro-5H-cyclopenta[b]pyridin-7-ol |
Molecular Weight: | 214.05 |
Molecular Formula: | C8H8NOBr |
Canonical SMILES: | C1CC2=C(C1O)N=CC(=C2)Br |
InChI: | InChI=1S/C8H8BrNO/c9-6-3-5-1-2-7(11)8(5)10-4-6/h3-4,7,11H,1-2H2 |
InChI Key: | OKOCPAPHUOPWDC-UHFFFAOYSA-N |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021178780-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 20200306 |
WO-2019201291-A1 | Histone acetyltransferase (hat) inhibitor and use thereof | 20180420 |
EP-3782995-A1 | Histone acetyltransferase (hat) inhibitor and use thereof | 20180420 |
US-2019256504-A1 | Cardiac sarcomere inhibitors | 20180119 |
WO-2019144041-A1 | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors | 20180119 |
AU-2019208331-A1 | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors | 20180119 |
BR-112020014428-A2 | compound, pharmaceutical composition, and, methods for the treatment of heart disease in an individual, for the treatment of a disease or condition that is associated with small left ventricular cavity and cavity obliteration, hyperdynamic contraction of the left ventricle, myocardial ischemia or cardiac fibrosis, for the treatment of a disease or condition selected from muscular dystrophies and glycogen storage diseases and for inhibition of the cardiac sarcomere | 20180119 |
CA-3087283-A1 | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors | 20180119 |
CN-111757875-A | Dihydrobenzofuran and indene analogs as inotropic agents | 20180119 |
EP-3740481-A1 | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors | 20180119 |
Complexity: | 153 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 212.97893 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 212.97893 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 33.1Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.1 |
-
Catalog: BB074488
((1R,3R)-3-Amino-cyclopentyl)-carbamic Acid tert-Butyl Ester
Detail
-
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB074213
((2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-(2-(trimethylsilyl)ethoxy)tetrahydro-2H-pyran-2-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB064244
((2S,3R)-4-(4-(((((3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl)oxy)carbonyl)amino)-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamic Acid Phenylmethyl Ester
Detail
-
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
-
Catalog: BB072640
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
Detail
-
Catalog: BB069928
((2S,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB069927
((2R,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[70684-84-3]
1-Boc-1,2,3,6-tetrahydropyridine-4-carboxylic Acid
-
[853029-57-9]
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
-
[784-04-3]
9-Acetylanthracene
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[86404-04-8]
3-O-Ethyl-L-ascorbic acid
-
[72320-38-8]
3-Azidopropanol
INDUSTRY LEADERS TRUST OUR PRODUCTS